Igor T.
- Country
- Germany
- Department
- Klinik für Urologie
Research Overview
- A Randomized Controlled Trial Evaluating the Efficacy of Lutetium (177Lu) Vipivotide Tetraxetan in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving Androgen Deprivation Therapy
- DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma
- Phase I Trial Evaluating Eftilagimod Alpha with Immunotherapeutic, Targeted, or Chemotherapeutic Agents in Advanced Solid Tumors
Data & Insights
Has run more than one trial at 7 of 46 partner sites.
Specializations
Oncology Focus
The investigator specializes in treating advanced stage solid tumors, with particular emphasis on innovative therapeutic approaches.
- Locally Advanced Tumors
- Metastatic Disease Management
Their research encompasses evaluation of novel therapeutic combinations for cancer treatment.
Specialized Cancer Types
The investigator has developed expertise in specific cancer types, including NSCLC adenocarcinomas and urothelial carcinomas.
- Lung Cancer Specialization
- Urological Oncology
Their work focuses on advanced and metastatic presentations of these malignancies.
Therapeutic Approaches
The investigator explores immunotherapeutic interventions and their combinations with other treatment modalities.
- Immunotherapy Applications
- Combination Therapy Strategies
- Novel Treatment Routes
Their research includes evaluation of innovative application methods for cancer therapeutics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.